It’s High Time For The Cannabis-Related Drug Pipeline

Zynerba Pharmaceuticals, Inc (NASDAQ: ZYNE) gave investors an update on its clinical program this week. Like weeds, specialty pharmaceutical companies have sprung up and engaged in developing commercially viable therapies based on cannabinoids, a primary compound found in cannabis. In light of the impending results from Zynerba, below is…

Insys Therapeutics reports 2Q loss

CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Thursday reported a second-quarter loss of $8.2 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Chandler, Arizona-based company said it had a loss of 11 cents. Earnings, adjusted for non-recurring costs…

Cara Therapeutics Reports Second Quarter 2017 Financial Results

STAMFORD, Conn., Aug. 03, 2017 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced financial results for the second quarter ended June 30, 2017. “During…

Cara Therapeutics Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Cara Therapeutics Inc (NASDAQ: CARA) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 4:30 PM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/23648. Replay…